Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stop & Shop Raises Record-Breaking $3.1 Million During Its Annual ’Help Cure Childhood .
Stop and ShopMay 5, 2021 GMT
QUINCY, Mass., May 05, 2021 (GLOBE NEWSWIRE) Stop & Shop today announced that its annual ‘Help Cure Childhood Cancer’ campaign raised a record-breaking $3.1 million for pediatric cancer research and care at Memorial Sloan Kettering Cancer Center (MSK) and Dana-Farber Cancer Institute. Stop & Shop will donate additional funding to the campaign, bringing the total donation to the hospitals to $4.25 million.
The campaign, which ran throughout the month of March, allowed customers to round-up their purchases to the nearest dollar or donate an additional $1, $3 or $5 when shopping in store and online. In New York, New Jersey, and Fairfield and New Haven counties in Connecticut, customer donations supported MSK Kids, Memorial Sloan Kettering’s pediatric oncology pro
E-Mail
A group of scientists have just made a key discovery that could prevent and eradicate immune responses that lead to treatment failure in about one-third of people with severe hemophilia A.
Hemophilia is the most common severe inherited bleeding disorder in men. The disease affects 1 in 10,000 males worldwide and results from deficiency of blood clotting factor VIII (FVIII). Both children and adults with hemophilia A (80 percent of all hemophilia) receive treatment that involves infusing FVIII protein into the bloodstream. However, about 30 percent of them develop an immune response in the form of antibodies to FVIII (inhibitors), rendering treatment ineffective and increasing risk of mortality.
Date Time
CHOP-led Research Study Identifies Key Target in Treatment-Resistant Hemophilia A
Researchers at Children’s Hospital of Philadelphia (CHOP) have identified a key target that may be responsible for treatment failure in about 30% of patients with hemophilia A. The target, known as B cell activating factor (BAFF), appears to promote antibodies against and inhibitors of the missing blood clotting factor that is given to these patients to control their bleeding episodes. The findings, published in the Journal of Clinical Investigation, raise the possibility of using anti-BAFF therapies, potentially in combination with immune tolerance therapies, to tame the immune response in some patients with severe hemophilia A.
Share
Photo: (Photo : Photo by Anna Shvets from Pexels)
A brain tumor is the primary cause of cancer-related fatalities in children and second most common to teens, but a unique treatment is coming.
Brain tumors are the increasing cause of cancer-related fatalities in children under the age of ten and the second most common cause of cancer deaths in people under twenty. While brain cancer remains one of the most challenging cancers to treat, researchers at Dana Farber/Boston Children s Cancer and Blood Disorders Center significantly improve survival rates in the coming years.
While survival rates for children with some forms of brain tumors have improved significantly in the last 30 years, current research aims to increase those rates in the coming years mainly. Scientists are concentrating their efforts on the fundamental genetic and genomic errors that cause tumors, as well as the components of the tumor s microenvironment.
BOSTON – Make-A-Wish
® Massachusetts and Rhode Island announced Dana-Farber Cancer Institute is the recipient of the 2021 Community Hero Award. Dana-Farber Cancer Institute President and Chief Executive Officer Laurie H. Glimcher, MD, received the award on April 10, 2021, at the Make-A-Wish
® Gala: Heroes for Hope, a live virtual event.
The Community Hero Award recognizes an organization or individual providing vital partnership in the Make-A-Wish Massachusetts and Rhode Island mission creating life-changing wishes for children with critical illnesses. Dana-Farber Cancer Institute has championed the Make-A-Wish mission for more than 30 years, referring more than 2,500 children in Massachusetts and Rhode Island to experience the powerful impact of a wish fulfilled.